Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyCBHA Pediatric Kidney Transplant Coverage | OpenPa…
    Ask Trek AI about this page
    CurrentCarolina Behavioral Health Alliance (CBHA)Policy CP.MP.246

    Pediatric Kidney Transplant

    Customize your policy alerts

    Sign up for carolinabehavioralhealth Policy CP.MP.246 alerts

    Get alerted when Policy CP.MP.246 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy establishes medical necessity criteria for kidney transplantation in pediatric members and enrollees under age 18 with advanced chronic kidney disease or end-stage renal disease. It applies to non-Medicare health plans and requires advanced renal disease without specified transplant contraindications.

    Policy Summary
    PayerCarolina Behavioral Health Alliance (CBHA)
    PolicyPediatric Kidney Transplant
    Policy CodePolicy CP.MP.246
    Change TypeRevised
    Effective DateN/A
    Last ReviewFeb 1, 2026
    Next Review DateN/A
    Key ActionDocument cardiology evaluation for active symptomatic cardiac disease and obtain cardiologist clearance after myocardial infarction before kidney transplantation.
    SourceLink
    POLICY UPDATE CHANGES

    The policy revised contraindications related to stroke, transient ischemic attack, and symptomatic cardiac disease to align them with the applicable body systems.

    The contraindication for acute pancreatitis was removed from the policy.

    <18 yearsEligible pediatric member age
    <15GFR threshold for stage 5 ESRD

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    <30GFR threshold for stage 4 CKD
    10Listed transplant contraindications
    3HIV documentation elements

    Medical Necessity Criteria

    Pediatric Kidney Transplant Medical Necessity

    Pediatric kidney transplantation is medically necessary for pediatric members/enrollees younger than 18 years when all of the following conditions are met:

    ALL of the following

    • Advanced renal disease including ONE of the following

      • End-stage renal disease (ESRD), stage 5, with glomerular filtration rate (GFR) < 15 mL/min/1.73 m².
      • Chronic kidney disease (CKD), stage 4, with GFR < 30 mL/min/1.73 m² in a member/enrollee who is expected to reach ESRD.
    • Does not have any of the listed contraindications.

    Patients with a GFR above 30 mL/min/1.73 m² who are rapidly progressing toward ESRD should be referred for kidney transplant evaluation.

    Active infection that is not properly treated is a contraindication, except for hepatitis C virus infection.

    HIV infection with a detectable viral load is a contraindication unless all of the following are documented: CD4 cell count > 200 cells/mm³; absence of active AIDS-defining opportunistic infection; and current treatment with effective antiretroviral therapy (ART).

    Active malignancy with a high risk of recurrence or death related to cancer is a contraindication.

    Stroke within the past six months or transient ischemic attack within the past three months is a contraindication.

    Active symptomatic cardiac disease, including angina, arrhythmia, heart failure, or valvular heart disease, that has not been evaluated by a cardiologist is a contraindication. If the member/enrollee has had a myocardial infarction, cardiologist clearance is required before kidney transplantation.

    Active symptomatic peripheral arterial disease that is not properly managed is a contraindication.

    Inability to adhere to the regimen necessary to preserve the transplant remains a contraindication, even with caregiver support.

    Active or ongoing substance use disorder that affects decision-making or places the member/enrollee at high post-transplant risk is a contraindication.

    Decompensated cirrhosis is a contraindication unless the member/enrollee is a candidate for combined liver-kidney transplantation.

    Elevated levels of circulating antiglomerular basement membrane antibodies are a contraindication.

    Billing and Clinical Thresholds

    CPT CodesCPT
    50300Donor nephrectomy (including cold preservation); from cadaver donor
    50320Unilateral or bilateral donor nephrectomy (including cold preservation); open, from living donor
    50323Donor nephrectomy (including cold preservation); open, from living donor; backbench standard preparation of cadaver donor renal allograft prior to transplantation, including dissection and removal of perinephric fat, diaphragmatic and retroperitoneal attachments, excision of adrenal gland, and preparation of ureter(s), renal vein(s), and renal artery(s), ligating branches as necessary
    50325Backbench standard preparation of living donor renal allograft (open or laparoscopic) prior to transplantation, including dissection and removal of perinephric fat and preparation of ureter(s), renal vein(s), and renal artery(s), ligating branches as necessary
    50327Backbench reconstruction of cadaver or living donor renal allograft prior to transplantation; venous anastomosis, each
    50328Backbench reconstruction of cadaver or living donor renal allograft prior to transplantation; arterial anastomosis, each
    50329Backbench reconstruction of cadaver or living donor renal allograft prior to transplantation; ureteral anastomosis, each
    50360Renal allotransplantation, implantation of graft; without recipient nephrectomy
    50365Renal allotransplantation, implantation of graft; with recipient nephrectomy
    50547Laparoscopy, surgical; donor nephrectomy (including cold preservation), from living donor
    HCPCS CodesHCPCS
    S2152Solid organ(s), complete or segmental, single organ or combination of organs; deceased or living donor(s), procurement, transplantation, and related complications; including drugs, supplies, hospitalization with outpatient follow-up, medical/surgical, diagnostic, emergency, and rehabilitative services, and the number of days of pre- and posttransplant care in the global definition
    Stage 5 ESRD
    ConditionEnd-stage renal disease (ESRD), stage 5
    GFR threshold< 15 mL/min/1.73 m2
    Transplant eligibility contextPediatric members/enrollees age < 18 may meet medical necessity when all policy conditions are met
    Stage 4 CKD
    ConditionChronic kidney disease (CKD), stage 4
    GFR threshold< 30 mL/min/1.73 m2
    Additional requirement

    Documentation and Denial Risks

    Documentation Required

    Document HIV eligibility

    For a member with HIV infection and a detectable viral load, document all required eligibility elements before kidney transplantation.

    • CD4 cell count > 200 cells/mm3
    • Absence of active AIDS-defining opportunistic infection
    • Current use of effective ART (antiretroviral therapy)
    Documentation Required

    Obtain cardiac evaluation and clearance

    Document cardiology evaluation for active symptomatic cardiac disease. If the member/enrollee has had a myocardial infarction, obtain clearance from a cardiologist prior to kidney transplant.

    • Evaluate active symptomatic cardiac disease, including angina, arrhythmia, heart failure, or valvular heart disease.
    • Obtain cardiologist clearance after myocardial infarction before transplantation.

    Pediatric Kidney Transplantation

    Kidney transplantation is the preferred treatment for pediatric patients with advanced chronic kidney disease or end-stage renal disease. Compared with dialysis, transplantation can improve quality of life, growth, and survival. For pediatric end-stage renal disease, preemptive transplantation is preferred because it is associated with lower mortality and better health outcomes. Candidate selection includes multidisciplinary assessment of the cause of kidney disease, transplant-related risks, adherence capacity, and overall suitability.

    Transplant Candidate Requirements

    Pediatric Kidney Transplant Candidate Criteria

    A pediatric candidate may meet medical necessity for kidney transplantation when ALL of the following conditions are satisfied.

    Required candidate criteria

    • Advanced renal disease — ONE of the following

      • Stage 5 ESRD: End-stage renal disease (ESRD), stage 5, is present.GFR <15 mL/min/1.73 m2
      • Stage 4 CKD progressing to ESRD: Chronic kidney disease (CKD), stage 4, is present and the candidate is expected to reach ESRD.GFR <30 mL/min/1.73 m2

    Conditions Excluding Coverage

    Pediatric kidney transplantation requires the absence of specified contraindications, including untreated active infection other than hepatitis C virus infection; detectable HIV viral load without the required CD4, infection, and antiretroviral-therapy documentation; active malignancy with high recurrence or cancer-related mortality risk; recent stroke or transient ischemic attack; unevaluated active symptomatic cardiac disease or myocardial infarction without cardiologist clearance; improperly managed symptomatic peripheral arterial disease; inability to follow the transplant-preservation regimen even with caregiver support; active or ongoing substance use disorder that affects decision-making or increases post-transplant risk; decompensated cirrhosis without eligibility for combined liver-kidney transplantation; or elevated circulating antiglomerular basement membrane antibodies.

    Referral and Clinical Evaluation

    Note

    Complete required transplant evaluation

    Patients with a GFR above 30 mL/min/1.73 m2 who are rapidly progressing toward ESRD should be referred for kidney transplant evaluation. Active symptomatic cardiac disease must be evaluated by a cardiologist, and cardiologist clearance is required after myocardial infarction before kidney transplantation.

    • Refer rapidly progressing patients with GFR above 30 mL/min/1.73 m2 for transplant evaluation.
    • Document cardiology evaluation for active symptomatic cardiac disease.
    • Obtain cardiologist clearance after myocardial infarction before transplantation.
    Policy Summary
    PayerCarolina Behavioral Health Alliance (CBHA)
    PolicyPediatric Kidney Transplant
    Policy CodePolicy CP.MP.246
    Change TypeRevised
    Effective DateN/A
    Last ReviewFeb 1, 2026
    Next Review DateN/A
    Key ActionDocument cardiology evaluation for active symptomatic cardiac disease and obtain cardiologist clearance after myocardial infarction before kidney transplantation.
    SourceLink
    On This Page
    Medical Necessity CriteriaBilling and Clinical ThresholdsDocumentation and Denial RisksPediatric Kidney TransplantationTransplant Candidate RequirementsConditions Excluding CoverageReferral and Clinical Evaluation
    Member/enrollee is expected to reach ESRD
    Denial Risk

    Screen for transplant contraindications

    Coverage may be denied when any listed transplant contraindication is present, including conditions that are untreated, unevaluated, high risk, or incompatible with safe post-transplant care.

    • Active infection that is not properly treated, except hepatitis C virus infection
    • Active malignancy with high risk of recurrence or cancer-related death
    • Stroke within the past six months or transient ischemic attack within the past three months
    • Active symptomatic cardiac disease not evaluated by a cardiologist, or myocardial infarction without cardiologist clearance
    • Active symptomatic peripheral arterial disease that is not properly managed
    • Inability to adhere to the transplant-preservation regimen, even with caregiver support
    • Active or ongoing substance use disorder affecting decision-making or creating high post-transplant risk
    • Decompensated cirrhosis unless the candidate is eligible for combined liver-kidney transplantation
    • Elevated circulating antiglomerular basement membrane antibodies
    Denial Risk

    Verify the renal disease threshold

    Coverage may be denied when the pediatric member does not have advanced renal disease meeting the policy’s ESRD or stage 4 CKD GFR criteria.

    • Stage 5 ESRD: GFR < 15 mL/min/1.73 m2
    • Stage 4 CKD: GFR < 30 mL/min/1.73 m2 in members/enrollees expected to reach ESRD
    No contraindications: The candidate does not have any of the following contraindications: active infection that is not properly treated, except hepatitis C virus infection; HIV infection with detectable viral load unless CD4 count is greater than 200 cells/mm3, no active AIDS-defining opportunistic infection is present, and effective antiretroviral therapy is being used; active malignancy with high risk of recurrence or death related to cancer; stroke within the past six months or transient ischemic attack within the past three months; active symptomatic cardiac disease not evaluated by a cardiologist, or myocardial infarction without cardiologist clearance before transplantation; active symptomatic peripheral arterial disease not properly managed; inability to adhere to the regimen necessary to preserve the transplant even with caregiver support; active or ongoing substance use disorder affecting decision-making or creating high post-transplant risk; decompensated cirrhosis unless eligible for combined liver-kidney transplantation; or elevated circulating antiglomerular basement membrane antibodies.